Overview:
As per the report of Market Research Future
(MRFR), the global pyrogen testing market is expected to show a CAGR of 9.8%
during the forecast period (2022-2030). In the process, the pyrogen testing market can successfully scale valuation of USD 1464.55 million by the end of
the review period. Pyrogen is a toxin produced by bacteria. This thermostable
substance, when administered parenterally, can trigger immunogenic response
causing fever in human beings. It can be present in vaccines, biotechnological
products, and drugs, but as its advantage, it can also read the presence
of microbes and their metabolites. The technology becomes important in
detecting the presence of pyrogen in substances such as drugs and vaccines. An
integral process of the drug makers, this
test ensures that the mixture lacks pyrogen so that the end-product does not
trigger any fever.
Increasing concern related to patient safety and stringent regulations to promote
safer drugs are the main thrusters for the pyrogen testing market. This has
ensured a rise in the production of innovative drugs and awareness regarding
products which is pushing the pyrogen testing market boundaries wider.
Increasing investment in the research & development sector and government
initiatives are to guide the market ahead in the coming years.
Segmentation:
MRFR, in their report on the global pyrogen
testing market, segmented the market by product, test type, application
and end-user for a better understanding.
Based on the product, the pyrogen testing
market can be segmented into instruments, services, kits, and reagents.
Based on the test type, the pyrogen testing
market can be segmented into recombinant factor C assay (rFC), limulus
amoebocyte lysate (LAL) test, monocyte activation test (MAT), and rabbit
pyrogen test (RPT). LAL test’s market proliferation is quite intense and its
popularity among the parenteral pharmaceuticals and medical device
manufacturing companies is on the rise.
Based on the application, the pyrogen
testing market can be segmented into pharmaceutical & biologics, medical
devices, and other applications systems.
Based on the end-user, the pyrogen testing market
includes medical device companies, pharmaceutical companies, biotechnology
companies, food and beverage companies. The pharmaceutical companies segment is
gaining much prominence.
Regional Analysis:
MRFR, in their latest report on the global
pyrogen testing market, included North America, Europe, Asia Pacific (APAC),
and the Middle East & Africa (MEA) for a region-specific analysis.
North America’s dominance in the global
sphere can be attributed to the presence of the U.S. The country has the superlative infrastructure for research &
development and a robust healthcare
system. The presence of several pharmaceuticals and biotech companies are
creating scope for the market to expand with great gusto.
Europe’s dominance
is a tad tinier than that of North America. The presence of several big
names such as France, Germany, the U.K., and others and their substantial
spending in the R & D sector to develop better drug can emerge as one the
major factors pushing the market ahead. The pyrogen testing demand is also
increasing as the immunity in the aged and children are really low and any kind
of secondary disease can adversely impact the healing process.
The emergence of APAC is quite riveting. As
developing economies trying to revamp their healthcare sector, a rise in investment regarding infrastructural
development has become significant. The regional market is quite alluring to
the global players for a number of reasons such as cost-effective resources and
labor.
The MEA market can contribute meagerly to
the global development of pyrogen testing market. The regional market has a poor infrastructure which can be a great
obstacle for the market growth during the forecast period. But a rise in
hospital number can ensure better growth for the pyrogen testing market in the
region.
Competitive
Landscape:
The pyrogen testing market players are Thermo Fisher Scientific,
Inc. (US), Ellab A/S (UK), Charles River
Laboratories, Inc. (US), GenScript (US), Hyglos GmbH (UK), Merck KGaA (UK),
Lonza (UK), Pyrostar (Japan), Wako Chemicals (US), Sanquin (UK), WuXi
PharmaTech (Cayman), Inc (China), Associates of Cape Cod, Inc. (US), and others.
In 2018, MilliporeSigma declared that they
are ready to collaborate with Solvias to create a new pyrogen testing kit. The
kit would be a cell-line-based Monocyte
Activation Test (MAT) kit.
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1 628
258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment